Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
20
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
News
Liquidia Secures $50 Million Funding Following YUTREPIA Commercial Launch and Legal Victory
Liquidia Corporation received $50 million from Healthcare Royalty following the first commercial sale of YUTREPIA and a favorable court ruling denying United Therapeutics' injunction request.
World's First Bioengineered External Liver Assist Device Treats Patient in Groundbreaking Clinical Trial
United Therapeutics and Intermountain Health successfully treated the world's first patient with miroliverELAP, a bioengineered external liver assist device, marking the first human clinical trial of a manufactured organ alternative.
United Therapeutics Completes Enrollment of Phase 3 Trial for Once-Daily Oral PAH Treatment Ralinepag
United Therapeutics has concluded enrollment of 728 participants in the phase 3 ADVANCE OUTCOMES study evaluating ralinepag, a potential first-in-class once-daily oral prostacyclin agonist for pulmonary arterial hypertension.
United Therapeutics Completes Enrollment in Phase 3 TETON 1 IPF Trial of Inhaled Treprostinil
United Therapeutics has fully enrolled its Phase 3 TETON 1 study, evaluating nebulized Tyvaso (treprostinil) for idiopathic pulmonary fibrosis (IPF).